BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7930653)

  • 1. A lacZ-based vector system for the rapid detection of V(D)J recombinase activity.
    Bühler B; Köhler G; Nielsen PJ
    J Immunol Methods; 1994 Oct; 175(2):259-66. PubMed ID: 7930653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel fluorescence-based system for assaying and separating live cells according to VDJ recombinase activity.
    Yancopoulos GD; Nolan GP; Pollock R; Prockop S; Li SC; Herzenberg LA; Alt FW
    Mol Cell Biol; 1990 Apr; 10(4):1697-704. PubMed ID: 2320007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V(D)J recombinase activity in primary and secondary murine lymphoid organs: assessment by a PCR assay with extrachromosomal plasmids.
    Abe M; Hayashida K; Takayama K; Shiku H
    Int Immunol; 1991 Oct; 3(10):1025-33. PubMed ID: 1756144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable expression of immunoglobulin gene V(D)J recombinase activity by gene transfer into 3T3 fibroblasts.
    Schatz DG; Baltimore D
    Cell; 1988 Apr; 53(1):107-15. PubMed ID: 3349523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5'-phosphorylated, RAG-dependent, and cell cycle regulated.
    Schlissel M; Constantinescu A; Morrow T; Baxter M; Peng A
    Genes Dev; 1993 Dec; 7(12B):2520-32. PubMed ID: 8276236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
    Oettinger MA; Schatz DG; Gorka C; Baltimore D
    Science; 1990 Jun; 248(4962):1517-23. PubMed ID: 2360047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of germline promoter PD beta 1 from the TCR beta locus causes hypermethylation that impairs D beta 1 recombination by multiple mechanisms.
    Whitehurst CE; Schlissel MS; Chen J
    Immunity; 2000 Nov; 13(5):703-14. PubMed ID: 11114382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequences affecting the V(D)J recombinational activity of the IgH intronic enhancer in a transgenic substrate.
    Fernex C; Caillol D; Capone M; Krippl B; Ferrier P
    Nucleic Acids Res; 1994 Mar; 22(5):792-8. PubMed ID: 8139920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The V(D)J recombination activating gene, RAG-1.
    Schatz DG; Oettinger MA; Baltimore D
    Cell; 1989 Dec; 59(6):1035-48. PubMed ID: 2598259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin D(H) recombination signal sequence targeting: effect of D(H) coding and flanking regions and recombination partner.
    VanDyk LF; Wise TW; Moore BB; Meek K
    J Immunol; 1996 Nov; 157(9):4005-15. PubMed ID: 8892634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin remodeling directly activates V(D)J recombination.
    Cherry SR; Baltimore D
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10788-93. PubMed ID: 10485904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both V(D)J recombination and radioresistance require DNA-PK kinase activity, though minimal levels suffice for V(D)J recombination.
    Kienker LJ; Shin EK; Meek K
    Nucleic Acids Res; 2000 Jul; 28(14):2752-61. PubMed ID: 10908332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of V(D)J recombinational accessibility by the intronic E kappa element: role of the kappa B motif.
    Demengeot J; Oltz EM; Alt FW
    Int Immunol; 1995 Dec; 7(12):1995-2003. PubMed ID: 8746569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V(D)J recombination activity in human hematopoietic cells: correlation with developmental stage and genome stability.
    Gauss GH; Domain I; Hsieh CL; Lieber MR
    Eur J Immunol; 1998 Jan; 28(1):351-8. PubMed ID: 9485214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inducible cell model for studies of V(D)J recombinational control.
    Sikes ML; Oltz EM
    J Immunol Methods; 1999 Apr; 224(1-2):25-9. PubMed ID: 10357203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
    Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
    Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody class switch recombinase activity is B cell stage specific and functions stochastically in the absence of 'targeted accessibility' control.
    Ballantyne J; Henry DL; Marcu KB
    Int Immunol; 1997 Jul; 9(7):963-74. PubMed ID: 9237105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V(D)J recombination and allelic exclusion of a TCR beta-chain minilocus occurs in the absence of a functional promoter.
    Alvarez JD; Anderson SJ; Loh DY
    J Immunol; 1995 Aug; 155(3):1191-202. PubMed ID: 7636187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling.
    Hertz M; Kouskoff V; Nakamura T; Nemazee D
    Nature; 1998 Jul; 394(6690):292-5. PubMed ID: 9685161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of V(D)J recombination by transcriptional promoters.
    Sikes ML; Suarez CC; Oltz EM
    Mol Cell Biol; 1999 Apr; 19(4):2773-81. PubMed ID: 10082543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.